Universal Prescription Drug Coverage: Rethinking Outpatient Pharmaceutical Provision in Alberta
Bibliographic record
Abstract
For years, healthcare researchers and economists have explored and expounded the advantages of implementing a national Pharmacare program in Canada. Yet, the federal government has resisted or ignored the arguments presented them. Now, facing sky-rocketing pharmaceutical prices, both individuals and governments are seeking novel approaches to mitigate drug costs and ultimately provide better health outcomes for all Canadians. This paper explores how Alberta might unilaterally implement a universal prescription drug program for its citizens. Comparing how different healthcare systems provide pharmaceutical benefits within their own, unique structures elucidates the variety of partnership and financing options available to Alberta. Overall, the research shows that success is best achieved by focusing first on how to improve health outcomes by identifying “at risk” populations and then addressing funding models based on efficacy, while maintaining the equity which is so valued in the Canadian healthcare system. In furtherance of this goal, the paper contains an assessment of how current partnerships and standards address the cost of prescription drugs and how best to integrate existing systems into a novel, uniquely Albertan prescription drug plan. The paper ultimately provides recommendations for government for the implementation of the plan. Successes achieved in other programs shows that by focusing our attention on specific populations and providing a fair and progressive financing model, Alberta can assume a leadership role by providing an efficient, equitable and sustainable drug plan for its residents.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.004 | 0.011 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.002 |
| Science and technology studies | 0.003 | 0.003 |
| Scholarly communication | 0.005 | 0.001 |
| Open science | 0.002 | 0.004 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.004 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".